JOURNAL 2748


Organic Communications
VOLUME & ISSUE
Year: 2023 Issue: 3 July-September
PAGES
p.174 - 174
STATISTICS
Viewed 477 times.
AUTHORS
  • Cenk A. Andac
PDF OF ARTICLE

GRAPHICAL ABSTRACT


ABSTRACT


It was wrongly indicated in the Acknowledgement section that a Turkish patent was received for 3-(2-methylthio10H-phenothiazine-10-yl-propyl)-pyrimidine-2,4-(1H,3H)-dione. This should be corrected as “For its novelty and great cytotoxic activity, a Turkish patent was applied (Applicationt ID: 2013/139199) for 3-(2-methylthio10H-phenothiazine-10-yl-propyl)-pyrimidine-2,4-(1H,3H)-dione. The patent application has still been under evaluation”. The author apologizes for this mistake

KEYWORDS
  • Erratum
  • phenothiazine derivatives